Navigation Links
New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group
Date:11/15/2010

TORONTO, Nov. 15, 2010 /PRNewswire/ -- Millennium Research Group (MRG), the global authority on medical technology market intelligence, has released its latest peripheral vascular research data for multiple geographies, including the US, Canada, Europe, Asia Pacific, and Latin America.

MRG's peripheral vascular reports cover minimally invasive and surgical treatments for peripheral artery disease, including stenting, percutaneous transluminal balloon angioplasty, and synthetic surgical bypass. The reports provide a breakdown of different interventions performed in the major vessel beds including carotid, renal, iliac, femoropopliteal, infrapopliteal, and arteriovenous access treatments. Some regions also include a review of newer technologies such as peripheral drug-eluting stents and drug-coated balloons, in addition to an analysis of the booming abdominal and thoracic aortic stent graft markets.

"Reports also provide a detailed analysis of the competitive landscape and include market shares and qualitative discussions of the leading competitors in each market segment," says Stephanie LaBelle, Manager of the Cardiovascular division at MRG.  "Based on primary research with industry professionals, MRG uses proprietary forecasting models to provide an in-depth examination of current and future trends in procedure volumes, unit sales, average selling prices, and market values over a 7-year period."

MRG's latest peripheral vascular reports include US Markets for Peripheral Vascular Devices 2011, European Markets for Peripheral Vascular Devices 2011, Asia Pacific Markets for Peripheral Vascular Devices 2011, Canadian Markets for Peripheral Vascular Devices 2011, and Latin American Markets for Peripheral Vascular Devices 2011.  Please contact Amy Krohn at 416-364-7776 ext. 101 or akrohn@mrg.net for further details.

About Millennium Research GroupMillennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Amy KrohnMillennium Research Group416-364-7776 ext. 101akrohn@mrg.netChris ComfortDecision Resources, Inc. 781-993-2597ccomfort@dresources.com
'/>"/>

SOURCE Millennium Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfizers Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
2. U.S. Market for Peripheral Vascular Devices 2010 now Available at ReportsandReports
3. Drug-Eluting Peripheral Stent Continues to Show Positive Data at Two Years
4. Japanese Peripheral Vascular Stent Procedures to Experience 11% Growth Through 2014
5. IDEV(R) Technologies Announces First Patient Enrolled in Multi-Center Clinical Trial of SUPERA(R) PERipheral Stent
6. Lower Extremity Peripheral Vascular Stent and Balloon Catheter Markets to Exceed $180 Million in Europe by 2013
7. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
8. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
9. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
10. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
11. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Medical Market Analysis 2016 - Forecast to 2022" report ... The report contains up to date financial data derived from ... of major trends with potential impact on the market during ... market segmentation which comprises of sub markets, regional and country ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at www.diabetesscholars.org by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Surgical Procedure Volumes: Global Analysis (United States, China, Japan, ... report to their offering. ... tool for healthcare business planners, provides surgical procedure volume ... surgery trends with an in-depth analysis of growth drivers ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented ... in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, ...
(Date:6/24/2016)... ... , ... National recruitment firm Slone Partners is pleased to announce ... experience, as Vice President of North American Capital Sales at HTG Molecular . ... sales team in the commercialization of the HTG EdgeSeq system and associated reagents in ...
Breaking Medicine News(10 mins):